Curetis' Series B - II Round

Curetis raised a round of funding on November 24, 2014.

Curetis (AMS:CURE) is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast, and cost-effective products for diagnosing severe infectious diseases. T…

Articles about Curetis' Series B - II Round: